Military Vaccine Approvals Based On Animal Studies Could Be Allowed By FDA
Executive Summary
Animal efficacy studies could support approval of new products to reduce or prevent the toxicity of chemical, biological, radiological or nuclear substances when efficacy cannot ethically be tested in humans, FDA proposed in a recent Federal Register notice.
You may also be interested in...
FDA Animal Efficacy Rule Drops Superiority Requirement For New Agents
FDA's final rule allowing drug approvals based on animal efficacy studies will permit more than one drug to be approved for an indication without a clear demonstration of superiority over existing products
FDA Animal Efficacy Rule Drops Superiority Requirement For New Agents
FDA's final rule allowing drug approvals based on animal efficacy studies will permit more than one drug to be approved for an indication without a clear demonstration of superiority over existing products
Animal Efficacy Rule Will Be “Flexible” About Species Needed – CBER’s Zoon
FDA will exercise more flexibility in the number of animal species required for testing before approval of counter-terrorism products under the final animal efficacy rule, Center for Biologics Evaluation & Research Director Kathy Zoon, PhD, said